Related content

A review of the anti-tumor effect of the combined administration of a cyclooxygenase-2 selective inhibitor and a non-specific immunostimulant protein-bound polysaccharide on an advanced colon cancer model using colon cancer cell lines

By              

Oncology Letters, Vol. 2, Iss. 3, 2011-01 ,pp. : 509-514

Spandidos Publications

Access to resources Recommend Favorite

Temsirolimus enhances the efficacy of cetuximab in colon cancer through a CIP2A-dependent mechanism

By Wang Hsei-Wei   Yang Shung-Haur   Huang Guan-Da   Lin Jen-Kou   Chen Wei-Shone   Jiang Jeng-Kai   Lan Yuan-Tzu   Lin Chun-Chi   Hwang Wei-Lun   Tzeng Cheng-Hwai   Li Anna   Yen Chueh-Chuan   Teng Hao-Wei  

Journal of Cancer Research and Clinical Oncology, Vol. 140, Iss. 4, 2014-04 ,pp. : 561-571

Springer Publishing Company

Access to resources Recommend Favorite

Bortezomib induces G2-M arrest in human colon cancer cells through ROS-inducible phosphorylation of ATM-CHK1

By                      

International Journal of Oncology, Vol. 41, Iss. 1, 2012-01 ,pp. : 76-82

Spandidos Publications

Access to resources Recommend Favorite

Antitumor effect of whole body hyperthermia with α-galactosylceramide in a subcutaneous tumor model of colon cancer

By Hattori Takeshi   Kokura Satoshi   Okuda Toshimitsu   Okayama Tetsuya   Takagi Tomohisa   Handa Osamu   Naito Yuji   Yoshida Norimasa   Yoshikawa Toshikazu  

International Journal of Hyperthermia, Vol. 23, Iss. 7, 2007-01 ,pp. : 591-598

Informa Healthcare

Access to resources Recommend Favorite

Antitumor activity of the HER2 dimerization inhibitor pertuzumab on human colon cancer cells in vitro and in vivo

By Pohl Michael   Stricker I.   Schoeneck A.   Schulmann K.   Klein-Scory S.   Schwarte-Waldhoff I.   Hasmann M.   Tannapfel A.   Schmiegel W.   Reinacher-Schick A.  

Journal of Cancer Research and Clinical Oncology, Vol. 135, Iss. 10, 2009-10 ,pp. : 1377-1386

Springer Publishing Company

Access to resources Recommend Favorite